Home › Head and Neck Squamous Cell Carcinoma › Wisconsin › Stevens Point
Head and Neck Squamous Cell Carcinoma clinical trials in Stevens Point, WI
7 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Stevens Point (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 2
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RecruitingPhase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RecruitingPhase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Philadelphia, PA26 studies
- Arlington, VA26 studies
- Chicago, IL25 studies
- Atlanta, GA23 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
Other studies in Stevens Point
- Lung Cancer10 studies
- Non-Small Cell Lung Cancer8 studies
- Prostate Cancer7 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Hypopharyngeal Cancer5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Melanoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.